IDEC-C2B8 ANTI-CD20 PHASE-II TRIAL - RESULTS ON BONE-MARROW AND PERIPHERAL-BLOOD TUMOR RESPONSE IN PATIENTS WITH LOW-GRADE NON-HODGKINS-LYMPHOMA (NHL) LYMPHOPROLIFERATIVE DISORDERS (LPD)/

Citation
D. Nguyen et al., IDEC-C2B8 ANTI-CD20 PHASE-II TRIAL - RESULTS ON BONE-MARROW AND PERIPHERAL-BLOOD TUMOR RESPONSE IN PATIENTS WITH LOW-GRADE NON-HODGKINS-LYMPHOMA (NHL) LYMPHOPROLIFERATIVE DISORDERS (LPD)/, Blood, 90(10), 1997, pp. 2277-2277
Citations number
NO
Categorie Soggetti
Hematology
Journal title
BloodACNP
ISSN journal
00064971
Volume
90
Issue
10
Year of publication
1997
Part
1
Supplement
1
Pages
2277 - 2277
Database
ISI
SICI code
0006-4971(1997)90:10<2277:IAPT-R>2.0.ZU;2-A